Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Matthew B Palmer, MD, PhD

Matthew B Palmer, MD, PhD

faculty photo
Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine

Contact information
Hospital of the University of Pennsylvania
6 Founders
3400 Spruce Street
Philadelphia, PA 19104
Education:
B.S. (Zoology and Russian)
Brigham Young University, 1998.
M.D. (Doctor of Medicine)
Emory University School of Medicine, 2008.
Ph.D. (Biochemistry, Cell, and Developmental Biology)
Emory University, 2008.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Li Szu-Yuan, Park Jihwan, Qiu Chengxiang, Han Seung Hyeok, Palmer Matthew B, Arany Zoltan, Susztak Katalin: Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy. JCI insight 2(14), Jul 2017.

Ghosn Muriel, Palmer Matthew B, Najem Catherine E, Haddad Danny, Merkel Peter A, Hogan Jonathan J: New-onset hepatitis C virus-associated glomerulonephritis following sustained virologic response with direct-acting antiviral therapy
. Clinical nephrology 87 (2017)(5): 261-266, May 2017.

Hogan Jonathan J, Palmer Matthew D, Loren Alison W, Laskin Benjamin L: Quiz Page May 2017: CKD and Nephrotic Syndrome After Allogeneic Hematopoietic Cell Transplantation. American journal of kidney diseases : the official journal of the National Kidney Foundation 69(5): A10-A13, May 2017.

Lim Mary Ann, Palmer Matthew, Trofe-Clark Jennifer, Bloom Roy D, Jackson Annette, Philogene Mary Carmelle, Kamoun Malek: Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies. Human immunology 78(4): 350-356, Apr 2017.

Beckerman Pazit, Bi-Karchin Jing, Park Ae Seo Deok, Qiu Chengxiang, Dummer Patrick D, Soomro Irfana, Boustany-Kari Carine M, Pullen Steven S, Miner Jeffrey H, Hu Chien-An A, Rohacs Tibor, Inoue Kazunori, Ishibe Shuta, Saleem Moin A, Palmer Matthew B, Cuervo Ana Maria, Kopp Jeffrey B, Susztak Katalin: Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nature medicine 23(4): 429-438, Apr 2017.

Ueda Yoshiyasu, Mohammed Imran, Song Delu, Gullipalli Damodar, Zhou Lin, Sato Sayaka, Wang Yuan, Gupta Shuchi, Cheng Zhongjian, Wang Hong, Bao Jialing, Mao Yingying, Brass Lawrence, Zheng X Long, Miwa Takashi, Palmer Matthew, Dunaief Joshua, Song Wen-Chao: Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation. Blood 129(9): 1184-1196, Mar 2017.

Mariani Laura H, Martini Sebastian, Barisoni Laura, Canetta Pietro A, Troost Jonathan P, Hodgin Jeffrey B, Palmer Matthew, Rosenberg Avi Z, Lemley Kevin V, Chien Hui-Ping, Zee Jarcy, Smith Abigail, Appel Gerald B, Trachtman Howard, Hewitt Stephen M, Kretzler Matthias, Bagnasco Serena M: Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Feb 2017.

Hogan Jonathan J, Lim Mary Ann, Palmer Matthew B, Bloom Roy D, Chung Raymond T, Sise Meghan E: Development of proteinuria and focal segmental glomerulosclerosis during direct acting antiviral therapy for hepatitis C virus infection (HEP-16-2474.R1). Hepatology (Baltimore, Md.) Feb 2017.

Bhagat Tushar D, Zou Yiyu, Huang Shizeng, Park Jihwan, Palmer Matthew B, Hu Caroline, Li Wejuan, Shenoy Niraj, Giricz Orsolya, Choudhary Gaurav, Yu Yiting, Ko Yi-An, Izquierdo Maria C, Park Ae Seo Deok, Vallumsetla Nishanth, Laurence Remi, Lopez Robert, Suzuki Masako, Pullman James, Kaner Justin, Gartrell Benjamin, Hakimi A Ari, Greally John M, Patel Bharvin, Benhadji Karim, Pradhan Kith, Verma Amit, Susztak Katalin: Notch pathway is activated via genetic and epigenetic alterations and is a therapeutic target in clear cell renal cancer. The Journal of biological chemistry Dec 2016.

Yui Jennifer C, Van Keer Jan, Weiss Brendan M, Waxman Adam J, Palmer Matthew B, D'Agati Vivette D, Kastritis Efstathios, Dimopoulos Meletios A, Vij Ravi, Bansal Dhruv, Dingli David, Nasr Samih H, Leung Nelson: Proteasome inhibitor associated thrombotic microangiopathy. American journal of hematology 91(9): E348-52, Sep 2016.

back to top
Last updated: 05/03/2017
The Trustees of the University of Pennsylvania